CClinicalTrials.gg
CompletedNCT00468468Updated Feb 5, 2016

Mentor Integration Study

An interventional study of CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor in CHESS and Cancer Mentor, CHESS Only and Mentor Only, sponsored by University of Wisconsin, Madison. Completed at 3 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-05.

Sponsored by University of Wisconsin, Madison · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Mentor Integration Project

This study will investigate the benefits of CHESS, a Human Cancer Mentor and the potential additional benefit of combining CHESS and a Cancer Mentor compared to Internet access for women diagnosed with breast cancer. Our goal is to advance interactive cancer communication systems, thus improving quality of life for patients and families facing cancer, especially underserved populations.

Primary Aims:

  • Determine if the Internet, CHESS, a Cancer Mentor, or a combination of CHESS and the Cancer Mentor improve quality of life for women with breast cancer
  • Determine which of the above conditions is most effective
  • Determine which of the above conditions is most cost efficient
02

Conditions studied

  • CHESS and Cancer Mentor
  • CHESS Only
  • Mentor Only
  • Control (Internet Only)

Keywords

  • breast cancer
  • Internet
  • computer
  • support
  • information
  • education
03

In context

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

Eligibility for this protocol is as follows:

  • All subjects must be within 2 months of their primary breast cancer diagnosis,
  • All subjects must be at least 18 years of age,
  • All subjects must be able to read and write English at the 6th-grade level
  • Not homeless
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
126 participants (actual)

Study arms

  • Experimental
    CHESS Condition

    Subjects who receive the CHESS (Comprehensive Health Enhancement Support System)

    Behavioral: CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor

  • Experimental
    Mentor Condition

    Subjects who receive access to a Human Cancer Mentor only

    Behavioral: CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor

  • Experimental
    CHESS + Mentor

    Subjects who receive the CHESS system plus a Human Cancer Mentor

    Behavioral: CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor

  • No intervention
    Internet Only

    Subjects receive routine care and nothing else

Interventions

  • BehavioralCHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor

    computer based education and support

06

What researchers measure

Primary outcomes

  1. Patient quality of life

    Time frame: throughout study

Secondary outcomes

  1. Self efficacy

    Time frame: throughout study

  2. Emotional well being

    Time frame: throughout study

07

Study locations

3 sites
  • Hartford Hospital
    Hartford, Connecticut 06102, United States
  • M.D. Anderson
    Houston, Texas 77030, United States
  • University of Wisconsin
    Madison, Wisconsin 53706, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00468468
Lead sponsor
University of Wisconsin, Madison
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
May 2, 2007
Start date
Sep 2003
Primary completion
Sep 2008
Completion
Sep 2008
Last update
Feb 5, 2016

Study contacts

Robert Hawkins, PhD.
principal investigator · University of Wisconsin, Madison
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion